Breaking News Instant updates and real-time market news.

SGMS

Scientific Games

$59.30

6 (11.26%)

, BYD

Boyd Gaming

$36.06

1.045 (2.98%)

08:49
05/15/18
05/15
08:49
05/15/18
08:49

Supreme Court ruling on sports betting positive for regionals, game tech, says BofA/Merrill

BofA/Merrill analyst Shaun Kelley notes that the Supreme Court ruled 6-3 to repeal the Professional and Amateur Sports Protection Act, which had effectively banned full sports betting in every state except Nevada. While the analyst expects operator margins to be low, he sees upside for all of regional gaming, while gaming tech could be a key beneficiary. Reflecting sports betting in higher multiples, Kelley raised his price targets for Boyd Gaming (BYD) to $45 from $42, Penn National (PENN) to $36 from $32, Scientific Games (SGMS) to $70 from $60, and International Game (IGT) to $36 from $34.

SGMS

Scientific Games

$59.30

6 (11.26%)

BYD

Boyd Gaming

$36.06

1.045 (2.98%)

PENN

Penn National

$33.75

1.51 (4.68%)

IGT

International Game

$29.35

0.9 (3.16%)

  • 15

    May

  • 17

    May

  • 29

    May

SGMS Scientific Games
$59.30

6 (11.26%)

09/18/17
STFL
09/18/17
NO CHANGE
Target $40
STFL
Hold
Scientific Games price target raised to $40 from $35 at Stifel
Stifel analyst Steven M. Wieczynski raised his price target on Scientific Games to $40 from $35 after recently meeting with management and coming away with a more positive bias and the sense the company is "finally hitting its stride" within the slot segment. However, he questions just how much of the improvement is priced in already and would prefer to assess the competitive offerings at the upcoming G2E Show before reconsidering his Hold rating, he tells investors.
05/14/18
JEFF
05/14/18
NO CHANGE
JEFF
Jefferies says Penn National, Caesars among winners from sports gaming ruling
After the Supreme Court ruled that the PASPA provision prohibiting state authorization of organized sports gambling violates the tenth amendment, Jefferies analyst David Katz reiterated his view on which companies are positioned to be key beneficiaries of the decision. He continues to identify Penn National (PENN) and Caesars (CSR) as among the top winners in terms of casino operators, followed by Eldorado Resorts (ERI), Churchill Downs (CHDN), Boyd Gaming (BYD), Monarch Casino (MCRI), and MGM Resorts (MGM). He also sees "location-agnostic" suppliers Scientific Games (SGMS) and International Game (IGT) as winners, Katz tells investors.
02/20/18
JEFF
02/20/18
INITIATION
Target $57
JEFF
Buy
Scientific Games initiated with a Buy at Jefferies
Jefferies analyst David Katz started Scientific Games with a Buy rating and $57 price target. The analyst calls the company his Focus Pick in the equipment and technology supplier segment of the gaming industry. Katz views the current valuation as "highly attractive" following the NYX acquisition and his sum of the parts analysis yields share prices of $56 and $76 per share on 2018 and 2019 estimates.
10/05/17
CHLM
10/05/17
NO CHANGE
Target $56
CHLM
Buy
Scientific Games price target raised to $56 from $45 at Craig-Hallum
Craig-Hallum analyst Mike Malouf raised his price target for Scientific Games to $56 from $45 saying that its new CEO Kevin Sheehan has started to guide the company into the execution stage of its transformation. The new CEO has completed the cost rationalization initiative, which should further drive free cash flow this year, and the company is taking advantage of the market to refinance some of its debt, lowering the effective interest rate and driving continued free cash flow growth, he adds. Malouf reiterates a Buy rating on the shares.
BYD Boyd Gaming
$36.06

1.045 (2.98%)

03/13/18
TLSY
03/13/18
INITIATION
TLSY
Market Perform
Boyd Gaming initiated with a Market Perform at Telsey Advisory
05/01/18
LEHM
05/01/18
UPGRADE
Target $40
LEHM
Overweight
Boyd Gaming upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Felicia Hendrix upgraded Boyd Gaming to Overweight and raised her price target for the shares to $40 from $33. The consumer remains strong, particularly in Las Vegas, while Boyd is embarking on profitability enhancing initiatives across is portfolio, Hendrix tells investors in a research note.
02/21/18
RHCO
02/21/18
NO CHANGE
Target $38
RHCO
Buy
Boyd Gaming price target lowered to $38 from $43 at SunTrust
SunTrust analyst C. Patrick Scholes lowered his price target on Boyd Gaming to $38 after a Q4 earnings miss, saying the "Las Vegas Locals" segment was the major soft spot while other segments were in line. The analyst also notes that the company has attributed some of the soft FY18 outlook to adverse weather conditions in the Midwest and South regions. Longer term, Scholes keeps his Buy rating on Boyd Gaming, stating he would be a buyer on weakness based on the company's Las Vegas prospects and avenues for continued M&A driven growth.
PENN Penn National
$33.75

1.51 (4.68%)

04/13/18
JEFF
04/13/18
NO CHANGE
JEFF
Jefferies sees opportunity in smid-cap casino stocks after selloff
The recent selloff in smid-cap casino stocks has been driven by the impact of severe weather in the regional markets as well as a challenging quarter in Las Vegas, Jefferies analyst David Katz tells investors in a research note. Following the release of positive March gross gaming revenue from several important regional markets, the context for the quarter is more positive, Katz adds. He believes the share selloff is overdone and presents opportunities in Caesars (CZR) and Penn National Gaming (PENN), among others.
04/27/18
RHCO
04/27/18
UPGRADE
Target $35
RHCO
Buy
Penn National upgraded to Buy at SunTrust on valuation
As reported earlier, SunTrust analyst C. Patrick Scholes upgraded Penn National to Buy from Hold and kept his $35 price target. Scholes says that the discount with which the company trades relative to its peers is "extreme" even though it has underperformed the competition, adding that companies with "objectively lower end portfolios" trade with a higher multiple. The analyst also notes that Penn National has some upside catalysts, including cost synergies from its acquisitions.
04/26/18
RHCO
04/26/18
UPGRADE
RHCO
Buy
Penn National upgraded to Buy from Hold at SunTrust
IGT International Game
$29.35

0.9 (3.16%)

12/04/17
DBAB
12/04/17
NO CHANGE
Target $34
DBAB
Buy
International Game joint venture news a positive, says Deutsche Bank
Deutsche Bank analyst Carlo Santarelli says International Game Technology and its joint venture partners officially accepting the renewal of the Italian Scratch & Win concession through September 2028 is positive news. The development removes a potential 2018 overhang while the terms of the existing contract were left as is, Santarelli tells investors in a research note. He keeps a Buy rating on International Game with a $34 price target.
02/20/18
JEFF
02/20/18
INITIATION
Target $33
JEFF
Buy
International Game initiated with a Buy at Jefferies
Jefferies analyst David Katz started International Game Technology with a Buy rating and $33 price target. The analyst views the story as a combination of the slot business turnaround and a stable lottery business.
11/29/17
ARGS
11/29/17
UPGRADE
Target $35
ARGS
Buy
International Game upgraded to Buy at Argus on steady rise in lottery business
As noted earlier, Argus analyst John Staszak upgraded International Game to Buy from Hold with a $35 price target. Staszak says his rating changes is based on the company's solid earnings and free cash flow, debt reduction measures, steady growth of lottery business, and projected benefits from a gradual transition toward server-based gaming.

TODAY'S FREE FLY STORIES

02:30
11/15/18
11/15
02:30
11/15/18
02:30
General news
FX Update: The Dollar has traded broadly softer »

FX Update: The Dollar has…

01:50
11/15/18
11/15
01:50
11/15/18
01:50
General news
Asian Market Wrap: »

Asian Market Wrap:…

APTX

Aptinyx

$24.75

-0.76 (-2.98%)

21:40
11/14/18
11/14
21:40
11/14/18
21:40
Initiation
Aptinyx initiated at Cantor Fitzgerald »

Aptinyx initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$4.75

-0.42 (-8.12%)

21:39
11/14/18
11/14
21:39
11/14/18
21:39
Initiation
Ovid Therapeutics initiated at Cantor Fitzgerald »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AXSM

Axsome Therapeutics

$2.82

-0.07 (-2.42%)

21:38
11/14/18
11/14
21:38
11/14/18
21:38
Initiation
Axsome Therapeutics initiated at Cantor Fitzgerald »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNLI

Denali Therapeutics

$17.53

0.24 (1.39%)

21:37
11/14/18
11/14
21:37
11/14/18
21:37
Initiation
Denali Therapeutics initiated at Cantor Fitzgerald »

Denali Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$2.34

-0.07 (-2.90%)

21:35
11/14/18
11/14
21:35
11/14/18
21:35
Initiation
Otonomy initiated at Cantor Fitzgerald »

Otonomy initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AAPL

Apple

$186.81

-5.42 (-2.82%)

20:46
11/14/18
11/14
20:46
11/14/18
20:46
Hot Stocks
Apple supplier AMS AG discontinues FY18 targets »

Ams updates its fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

WEI

Weidai

$0.00

(0.00%)

20:33
11/14/18
11/14
20:33
11/14/18
20:33
Syndicate
Weidai 4.5M share IPO priced at $10.00 »

The deal was priced at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CPB

Campbell Soup

$39.16

-0.1 (-0.25%)

20:31
11/14/18
11/14
20:31
11/14/18
20:31
Hot Stocks
Campbell Soup responds to ISS regarding board elections »

Campbell Soup issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CRM

Salesforce

$129.25

-2.93 (-2.22%)

20:25
11/14/18
11/14
20:25
11/14/18
20:25
Periodicals
Breaking Periodicals news story on Salesforce »

Salesforce to accommodate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 06

    Dec

  • 11

    Dec

  • 03

    Mar

WMT

Walmart

$101.58

-1.37 (-1.33%)

, JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

20:25
11/14/18
11/14
20:25
11/14/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

WMT

Walmart

$101.58

-1.37 (-1.33%)

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

BERY

Berry Global

$45.91

-0.49 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

BHVN

Biohaven Pharmaceutical

$33.70

-3.18 (-8.62%)

19:53
11/14/18
11/14
19:53
11/14/18
19:53
Recommendations
Biohaven Pharmaceutical analyst commentary at Piper Jaffray »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

LOXO

Loxo Oncology

$143.69

-15.62 (-9.80%)

19:51
11/14/18
11/14
19:51
11/14/18
19:51
Initiation
Loxo Oncology initiated at Raymond James »

Loxo Oncology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

OCUL

Ocular Therapeutix

$5.06

-0.25 (-4.71%)

19:50
11/14/18
11/14
19:50
11/14/18
19:50
Initiation
Ocular Therapeutix initiated at Raymond James »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Dec

VYGR

Voyager Therapeutics

$11.25

-0.54 (-4.58%)

19:49
11/14/18
11/14
19:49
11/14/18
19:49
Upgrade
Voyager Therapeutics rating change at Raymond James »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GLPG

Galapagos NV

$103.79

1.03 (1.00%)

19:48
11/14/18
11/14
19:48
11/14/18
19:48
Initiation
Galapagos NV initiated at Raymond James »

Galapagos NV initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COPY

CopyTele

$0.00

(0.00%)

19:47
11/14/18
11/14
19:47
11/14/18
19:47
Upgrade
CopyTele rating change at BMO Capital »

CopyTele upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$21.43

-0.04 (-0.19%)

19:40
11/14/18
11/14
19:40
11/14/18
19:40
Syndicate
VICI Properties 30M share Secondary priced at $21.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

WHD

Cactus

$32.37

-0.7 (-2.12%)

19:37
11/14/18
11/14
19:37
11/14/18
19:37
Hot Stocks
Cactus names Stephen Tadlock new CFO »

Cactus announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVLT

Revolution Lighting

$1.42

(0.00%)

19:32
11/14/18
11/14
19:32
11/14/18
19:32
Hot Stocks
Revolution Lighting receives revised $1.50 per share proposal from RVL LLC »

Revolution Lighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$8.34

-0.265 (-3.08%)

19:20
11/14/18
11/14
19:20
11/14/18
19:20
Periodicals
General Electric withdraws from Nigeria rail concession, Reuters says »

GE has withdrawn from a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCSF

Bain Capital Specialty Finance

$0.00

(0.00%)

19:11
11/14/18
11/14
19:11
11/14/18
19:11
Syndicate
Bain Capital Specialty Finance 7.5M share IPO price $20.25 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TSLA

Tesla

$344.07

5.36 (1.58%)

19:07
11/14/18
11/14
19:07
11/14/18
19:07
Periodicals
Tesla Model 3 owners experience issues in cold weather, Electrek says »

Tesla Model 3 will face…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 19

    Nov

  • 13

    Dec

NGHC

National General

$24.75

-3.05 (-10.97%)

19:05
11/14/18
11/14
19:05
11/14/18
19:05
Syndicate
National General 5M share Secondary priced at $24.00 »

JPMorgan, Goldman Sachs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.